ARID1A and cancer: Similarly, ARID1A, which is characterized predominantly by the SNA type of genetic alterations, showed ConsensusDriver potential in many cancer types (Fig. 4A) but did not appear among the top 100 Pan-Cancer Driver ERGs (Fig. 4D; Supplemental Fig. S5B).